The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Open accessAbstract
Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child. Genomics has illuminated the extensive intertumoral heterogeneity of medulloblastoma, identifying four distinct molecular subgroups. Group 3 and group 4 subgroup medulloblastomas account for most paediatric cases; yet, oncogenic drivers for these subtypes remain largely unidentified. Here we describe a series of prevalent, highly disparate genomic structural variants, restricted to groups 3 and 4, resulting in specific and mutually exclusive activation of the growth factor independent 1 family proto-oncogenes, GFI1 and GFI1B. Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity. Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies have shown that the ‘hijacking’ of enhancers can lead to overexpression of oncogenes (for example, growth factor independent 1 family oncogenes (GFI1 and GFI1B)) in medulloblastoma13”
From Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (2020) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ostrom, Q. T., Gittleman, H. R., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz‐Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 12,063
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications
Krueger, F., & Andrews, S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr167 · Cited by 5,324
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Mapping and analysis of chromatin state dynamics in nine human cell types
Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898
Cited by
Sorted by citations
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X. L., Fernandez‐Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,362
Self-citationThe landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572
Self-citationSomatic mutation in cancer and normal cells
Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cavalli, F. M. G., Remke, M., Rampasek, L., Peacock, J., Shih, D. J. H., Luu, B., Garzia, L., Torchia, J., Nor, C., Morrissy, A. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.005 · Cited by 1,219
Self-citationMackay, A., Burford, A., Carvalho, D., Izquierdo, E., Fazal-Salom, J., Taylor, K. R., Bjerke, L., Clarke, M., Vinci, M., Nandhabalan, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.017 · Cited by 1,212
Self-citationTranscriptional Addiction in Cancer
Bradner, J. E., Hnisz, D., & Young, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.12.013 · Cited by 1,229
The whole-genome landscape of medulloblastoma subtypes
Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., et al. (2017) · Nature · doi:10.1038/nature22973 · Cited by 1,112
Self-citationChallenges to curing primary brain tumours
Aldape, K., Brindle, K. M., Chesler, L., Chopra, R., Gajjar, A., Gilbert, M. R., Gottardo, N., Gutmann, D. H., Hargrave, D., Holland, E. C., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0177-5 · Cited by 959
Self-citationChromatin Domains: The Unit of Chromosome Organization
Dixon, J. R., Gorkin, D. U., & Ren, B. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.018 · Cited by 811
Pott, S., & Lieb, J. D. (2014) · Nature Genetics · doi:10.1038/ng.3167 · Cited by 786
Structural variation in the 3D genome
Spielmann, M., Lupiáñez, D. G., & Mundlos, S. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0007-0 · Cited by 752
The role of 3D genome organization in development and cell differentiation
Zheng, H., & Xie, W. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0132-4 · Cited by 742
Fujimoto, A., Furuta, M., Totoki, Y., Tsunoda, T., Kato, M., Shiraishi, Y., Tanaka, H., Taniguchi, H., Kawakami, Y., Ueno, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3547 · Cited by 704
Northcott, P. A., Robinson, G. W., Kratz, C. P., Mabbott, D., Pomeroy, S. L., Clifford, S. C., Rutkowski, S., Ellison, D. W., Malkin, D. M., Taylor, M. D., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0063-6 · Cited by 673
Self-citationRisk stratification of childhood medulloblastoma in the molecular era: the current consensus
Ramaswamy, V., Remke, M., Bouffet, E., Bailey, S., Clifford, S. C., Doz, F., Kool, M., Dufour, C., Vassal, G., Milde, T., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1569-6 · Cited by 654
Self-citationAberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Kataoka, K., Shiraishi, Y., Takeda, Y., Sakata, S., Matsumoto, M., Nagano, S., Maeda, T., Nagata, Y., Kitanaka, A., Mizuno, S., et al. (2016) · Nature · doi:10.1038/nature18294 · Cited by 659
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Rheinbay, E., Nielsen, M. M., Abascal, F., Wala, J. A., Shapira, O., Tiao, G., Hornshøj, H., Hess, J. M., Juul, R. I., Lin, Z., et al. (2020) · Nature · doi:10.1038/s41586-020-1965-x · Cited by 611
Self-citationTelomerase activation by genomic rearrangements in high-risk neuroblastoma
Peifer, M., Hertwig, F., Roels, F., Dreidax, D., Gartlgruber, M., Menon, R., Krämer, A., Roncaioli, J. L., Sand, F., Heuckmann, J. M., et al. (2015) · Nature · doi:10.1038/nature14980 · Cited by 613
Convergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers
Hnisz, D., Schuijers, J., Lin, C. Y., Weintraub, A. S., Abraham, B. J., Lee, T. I., Bradner, J. E., & Young, R. A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.014 · Cited by 476
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Fang, Y., Liao, G., & Yu, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0811-9 · Cited by 453
Integrative detection and analysis of structural variation in cancer genomes
Dixon, J. R., Xu, J., Dileep, V., Zhan, Y., Song, F., Le, V. T., Yardımcı, G. G., Chakraborty, A., Bann, D. V., Wang, Y., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0195-8 · Cited by 452
Role of non-coding sequence variants in cancer
Khurana, E., Fu, Y., Chakravarty, D., Demichelis, F., Rubin, M. A., & Gerstein, M. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.17 · Cited by 459
Breaking TADs: How Alterations of Chromatin Domains Result in Disease
Lupiáñez, D. G., Spielmann, M., & Mundlos, S. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.01.003 · Cited by 439
Weischenfeldt, J., Dubash, T., Drainas, A. P., Mardin, B. R., Chen, Y., Stütz, A. M., Waszak, S. M., Bosco, G., Halvorsen, A. R., Raeder, B., et al. (2017) · Nature Genetics · doi:10.1038/ng.3722 · Cited by 404
Self-citationThe role of enhancers in cancer
Sur, I., & Taipale, J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.62 · Cited by 393
Whole genome sequencing analysis for cancer genomics and precision medicine
Nakagawa, H., & Fujita, M. (2018) · Cancer Science · doi:10.1111/cas.13505 · Cited by 387
Active medulloblastoma enhancers reveal subgroup-specific cellular origins
Lin, C. Y., Erkek, S., Tong, Y., Yin, L., Alexander Joel Federation, Zapatka, M., Haldipur, P., Kawauchi, D., Risch, T., Warnatz, H.-J., et al. (2016) · Nature · doi:10.1038/nature16546 · Cited by 382
Self-citationViswanathan, S. R., Ha, G., Hoff, A. M., Wala, J. A., Carrot-Zhang, J., Whelan, C. W., Haradhvala, N. J., Freeman, S. S., Reed, S. C., Rhoades, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.036 · Cited by 365
Highly rearranged chromosomes reveal uncoupling between genome topology and gene expression
Ghavi-Helm, Y., Jankowski, A., Meiers, S., Viales, R. R., Korbel, J. O., & Furlong, E. E. M. (2019) · Nature Genetics · doi:10.1038/s41588-019-0462-3 · Cited by 354
Self-citationSuper-Enhancer-Driven Transcriptional Dependencies in Cancer
Sengupta, S., & George, R. E. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.03.006 · Cited by 354
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers
Zhang, X., Choi, P. S., Francis, J. M., Imielinski, M. B., Watanabe, H., Cherniack, A. D., & Meyerson, M. M. (2015) · Nature Genetics · doi:10.1038/ng.3470 · Cited by 348
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma
Koche, R. P., Rodríguez-Fos, E., Helmsauer, K., Burkert, M., MacArthur, I. C., Mååg, J. L. V., González, R. C., Perez, N. M., Puiggròs, M., García, H. D., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0547-z · Cited by 343
Functional Enhancers Shape Extrachromosomal Oncogene Amplifications
Morton, A. R., Dogan-Artun, N., Faber, Z. J., MacLeod, G. D. A. H., Bartels, C. F., Piazza, M. S., Allan, K. C., Mack, S. C., Wang, X., Gimple, R. C., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.039 · Cited by 336
Divergent clonal selection dominates medulloblastoma at recurrence
Morrissy, A. S., Garzia, L., Shih, D. J. H., Zuyderduyn, S., Huang, X., Skowron, P., Remke, M., Cavalli, F. M. G., Ramaswamy, V., Lindsay, P. E., et al. (2016) · Nature · doi:10.1038/nature16478 · Cited by 336
Self-citationN-methyladenine DNA Modification in Glioblastoma
Xie, Q., Wu, T., Gimple, R. C., Li, Z., Prager, B. C., Wu, Q., Yu, Y., Wang, P., Wang, Y., Gorkin, D. U., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.006 · Cited by 327
Takeda, D. Y., Spisák, S., Seo, J.-H., Bell, C., O’Connor, E., Korthauer, K., Ribli, D., Csabai, I., Solymosi, N., Szállási, Z., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.037 · Cited by 317
Regulation of disease-associated gene expression in the 3D genome
Krijger, P. H. L., & de Laat, W. L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.138 · Cited by 332
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Xiao, L., Parolia, A., Qiao, Y., Bawa, P., Eyunni, S., Mannan, R., Carson, S. E., Chang, Y., Wang, X., Zhang, Y., et al. (2021) · Nature · doi:10.1038/s41586-021-04246-z · Cited by 324
Sharma, T., Schwalbe, E. C., Williamson, D., Sill, M., Hovestadt, V., Mynarek, M., Rutkowski, S., Robinson, G. W., Gajjar, A., Cavalli, F., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02020-0 · Cited by 310
Self-citationAn oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
Drier, Y., Cotton, M. J., Williamson, K. E., Gillespie, S. M., Ryan, R. J. H., Kluk, M., Carey, C. D., Rodig, S. J., Sholl, L. M., Afrogheh, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3502 · Cited by 306
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
Akdemir, K. C., Le, V. T., Chandran, S., Li, Y., Verhaak, R. G., Beroukhim, R., Campbell, P. J., Chin, L., Dixon, J. R., Futreal, P. A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0564-y · Cited by 283
Self-citationMedulloblastoma in the age of molecular subgroups: a review
Juraschka, K., & Taylor, M. D. (2019) · Journal of Neurosurgery Pediatrics · doi:10.3171/2019.5.peds18381 · Cited by 276
Self-citationMYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
Bandopadhayay, P., Ramkissoon, L. A., Jain, P., Bergthold, G., Wala, J. A., Zeid, R., Schumacher, S. E., Urbanski, L. M., O’Rourke, R., Gibson, W. J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3500 · Cited by 273
Medulloblastomics revisited: biological and clinical insights from thousands of patients
Hovestadt, V., Ayrault, O., Swartling, F. J., Robinson, G. W., Pfister, S. M., & Northcott, P. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0223-8 · Cited by 271
Self-citationSt. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem
McLeod, C., Gout, A. M., Zhou, X., Thrasher, A., Rahbarinia, D., Brady, S. W., Macias, M., Birch, K., Finkelstein, D., Sunny, J., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1230 · Cited by 274
Liquid–liquid phase separation in tumor biology
Tong, X., Tang, R., Xu, J., Wang, W., Zhao, Y., Yu, X., & Shi, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01076-x · Cited by 265
Self-citationClonal expansion in non-cancer tissues
Kakiuchi, N., & Ogawa, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00335-3 · Cited by 252
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
Wiesner, T., Lee, W., Obenauf, A. C., Ran, L., Murali, R., Zhang, Q. F., Wong, E. W. P., Hu, W., Scott, S. N., Shah, R. H., et al. (2015) · Nature · doi:10.1038/nature15258 · Cited by 254
Zimmerman, M. W., Liu, Y., He, S., Durbin, A. D., Abraham, B. J., Easton, J. B., Shao, Y., Xu, B., Zhu, S., Zhang, X., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0993 · Cited by 236
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma
Helmsauer, K., Valieva, M. E., Ali, S., González, R. C., Schöpflin, R., Röefzaad, C., Bei, Y., García, H. D., Rodríguez-Fos, E., Puiggròs, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19452-y · Cited by 229
TAD disruption as oncogenic driver
Valton, A.-L., & Dekker, J. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.03.008 · Cited by 241
Sun, Y., Wu, L. L., Liu, S., Jiang, M., Hu, B., Zhou, K., Guo, W., Xu, Y., Zhong, Y., Zhou, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24386-0 · Cited by 230
Gajjar, A. J., Bowers, D. C., Karajannis, M. A., Leary, S. E. S., Witt, H., & Gottardo, N. G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.9217 · Cited by 222
Self-citationLy, P., Brunner, S. F., Shoshani, O., Kim, D. H., Lan, W., Pyntikova, T., Flanagan, A. M., Behjati, S., Page, D. C., Campbell, P. J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0360-8 · Cited by 223
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia
Kloetgen, A., Thandapani, P., Ntziachristos, P., Ghebrechristos, Y. E., Nomikou, S., Lazaris, C., Chen, X., Hu, H., Bakogianni, S., Wang, J., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0602-9 · Cited by 219
Newman, S., Nakitandwe, J., Kesserwan, C. A., Azzato, E. M., Wheeler, D. A., Rusch, M., Shurtleff, S. A., Hedges, D. J., Hamilton, K. V., Foy, S. G., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1631 · Cited by 226
Self-citationSubtype-specific 3D genome alteration in acute myeloid leukaemia
Xu, J., Song, F., Lyu, H., Kobayashi, M., Zhang, B., Zhao, Z., Hou, Y., Wang, X., Luan, Y., Jia, B., et al. (2022) · Nature · doi:10.1038/s41586-022-05365-x · Cited by 208
Maiqués-Díaz, A., Spencer, G. J., Lynch, J. T., Ciceri, F., Williams, E. L., Amaral, F. M. R., Wiseman, D. H., Harris, W. J., Li, Y., Sahoo, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.012 · Cited by 208
Haller, F., Bieg, M., Will, R. D., Körner, C., Weichenhan, D., Bott, A., Ishaque, N., Lutsik, P., Moskalev, E. A., Mueller, S. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08069-x · Cited by 209
Self-citationMcArthur, E., & Capra, J. A. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.01.001 · Cited by 207
Medulloblastoma—translating discoveries from the bench to the bedside
Gajjar, A. J., & Robinson, G. W. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.181 · Cited by 194
Self-citationEnhancer selectivity in space and time: from enhancer–promoter interactions to promoter activation
Yang, J. H., & Hansen, A. S. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00710-6 · Cited by 191
Medulloblastoma: From Myth to Molecular
Ramaswamy, V., & Taylor, M. D. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.7842 · Cited by 186
Self-citationThe Epigenetic Hallmarks of Cancer
Esteller, M., Dawson, M. A., Kadoch, C., Rassool, F. V., Jones, P. A., & Baylin, S. B. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0296 · Cited by 202
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis
Kamber, R. A., Nishiga, Y., Morton, B., Banuelos, A. M., Barkal, A. A., Vences‐Catalán, F., Gu, M., Fernández, D., Seoane, J. A., Yao, D., et al. (2021) · Nature · doi:10.1038/s41586-021-03879-4 · Cited by 179
Gimple, R. C., Kidwell, R. L., Kim, L. J. Y., Sun, T., Gromovsky, A. D., Wu, Q., Wolf, M. E., Lv, D., Bhargava, S., Jiang, L., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0061 · Cited by 182
Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia
Montefiori, L. E., Bendig, S., Gu, Z., Chen, X., Pölönen, P., Ma, X., Murison, A., Zeng, A. G. X., García‐Prat, L., Dickerson, K. M., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0145 · Cited by 189
The genomic landscape of cutaneous melanoma
Zhang, T., Dutton‐Regester, K., Brown, K. M., & Hayward, N. K. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12459 · Cited by 182
A biobank of patient-derived pediatric brain tumor models
Brabetz, S., Leary, S. E. S., Gröbner, S. N., Nakamoto, M. W., Seker‐Cin, H., Girard, E. J., Cole, B., Strand, A. D., Bloom, K., Hovestadt, V., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0207-3 · Cited by 178
Self-citationModeling medulloblastoma in vivo and with human cerebellar organoids
Ballabio, C., Anderle, M., Gianesello, M., Lago, C., Miele, E., Cardano, M., Aiello, G., Piazza, S., Caron, D., Gianno, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13989-3 · Cited by 181
Enhancers in disease: molecular basis and emerging treatment strategies
Claringbould, A., & Zaugg, J. B. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.012 · Cited by 179
VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma
Yao, X., Tan, J. Y., Lim, K. J., Koh, J., Ooi, W. F., Li, Z., Huang, D., Xing, M., Chan, Y. S., Qu, J. Z., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0375 · Cited by 171
Thandapani, P. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.014 · Cited by 167
Krefting, J., Andrade-Navarro, M. A., & Ibn-Salem, J. (2018) · BMC Biology · doi:10.1186/s12915-018-0556-x · Cited by 169
Unified rhombic lip origins of group 3 and group 4 medulloblastoma
Smith, K. S., Bihannic, L., Gudenas, B. L., Haldipur, P., Tao, R., Gao, Q., Li, Y., Aldinger, K. A., Iskusnykh, I. Y., Chizhikov, V. V., et al. (2022) · Nature · doi:10.1038/s41586-022-05208-9 · Cited by 168
Self-citationFailure of human rhombic lip differentiation underlies medulloblastoma formation
Hendrikse, L. D., Haldipur, P., Saulnier, O., Millman, J., Sjoboen, A. H., Erickson, A. W., Ong, W., Gordon, V. D., Coudière-Morrison, L., Mercier, A. L., et al. (2022) · Nature · doi:10.1038/s41586-022-05215-w · Cited by 167
Self-citationPathology, diagnostics, and classification of medulloblastoma
Orr, B. A. (2020) · Brain Pathology · doi:10.1111/bpa.12837 · Cited by 169
Franco, H. L., Nagari, A., Malladi, V. S., Li, W., Xi, Y., Richardson, D., Allton, K. L., Tanaka, K. Y., Li, J., Murakami, S., et al. (2017) · Genome Research · doi:10.1101/gr.226019.117 · Cited by 157
Aberrant Super‐Enhancer Landscape in Human Hepatocellular Carcinoma
Tsang, F. H., Law, C., Tang, T. C. C., Cheng, C. L., Chin, D. W., Tam, V., Wei, L., Wong, C. C., Ng, I. O., & Wong, C. (2019) · Hepatology · doi:10.1002/hep.30544 · Cited by 157
Wang, X., Xu, J., Zhang, B., Hou, Y., Song, F., Lyu, H., & Yue, F. (2021) · Nature Methods · doi:10.1038/s41592-021-01164-w · Cited by 152
Forget, A., Martignetti, L., Puget, S., Calzone, L., Brabetz, S., Picard, D. J., Montagud, A., Liva, S., Sta, A., Dingli, F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.08.002 · Cited by 154
Self-citationLooking beyond the genes: the role of non-coding variants in human disease
Spielmann, M., & Mundlos, S. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw205 · Cited by 154
The molecular landscape of ETMR at diagnosis and relapse
Lambo, S., Gröbner, S. N., Rausch, T., Waszak, S. M., Schmidt, C., Gorthi, A., Romero, J. C., Mauermann, M., Brabetz, S., Krausert, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1815-x · Cited by 151
Self-citationSuper-enhancer function and its application in cancer targeted therapy
Tang, F., Yang, Z., Tan, Y., & Li, Y. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0108-z · Cited by 145
Spatial heterogeneity in medulloblastoma
Morrissy, A. S., Cavalli, F. M. G., Remke, M., Ramaswamy, V., Shih, D. J. H., Holgado, B., Farooq, H., Donovan, L., Garzia, L., Agnihotri, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3838 · Cited by 143
Self-citation3D Genome of macaque fetal brain reveals evolutionary innovations during primate corticogenesis
Luo, X., Liu, Y., Dang, D., Hu, T., Hou, Y., Meng, X., Zhang, F., Li, T., Wang, C., Li, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.001 · Cited by 140
Riemondy, K. A., Venkataraman, S., Willard, N., Nellan, A., Sanford, B. L., Griesinger, A. M., Amani, V. M., Mitra, S. S., Hankinson, T. C., Handler, M. H., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noab135 · Cited by 138
Self-citationRyan, R. J. H., Drier, Y., Whitton, H. J., Cotton, M. J., Kaur, J., Issner, R., Gillespie, S. M., Epstein, C. B., Nardi, V., Sohani, A. R., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0370 · Cited by 127
Computational analysis of cancer genome sequencing data
Cortés‐Ciriano, I., Gulhan, D., Lee, J. J.-K., Melloni, G. E. M., & Park, P. J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00431-y · Cited by 118
Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies
Wang, J., Garancher, A., Ramaswamy, V., & Wechsler-Reya, R. J. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-013838 · Cited by 113
Self-citationNested epistasis enhancer networks for robust genome regulation
Lin, X., Liu, Y., Liu, S., Zhu, X., Wu, L., Zhu, Y., Zhao, D., Xu, X., Chemparathy, A., Wang, H., et al. (2022) · Science · doi:10.1126/science.abk3512 · Cited by 112
Pan-cancer analysis of whole genomesPreprint
Campbell, P. J., Getz, G., Stuart, J. M., Korbel, J. O., & Stein, L. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/162784 · Cited by 117
Self-citationFrom cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation
Möröy, T., Vaßen, L., Wilkes, B. C., & Khandanpour, C. (2015) · Blood · doi:10.1182/blood-2015-06-655043 · Cited by 114
Structural variations in cancer and the 3D genome
Dubois, F. P. B., Sidiropoulos, N., Weischenfeldt, J., & Beroukhim, R. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00488-9 · Cited by 112
Enhancer deregulation in cancer and other diseases
Herz, H. (2016) · BioEssays · doi:10.1002/bies.201600106 · Cited by 110
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
Martin‐García, D., Navarro, A., Valdés‐Mas, R., Clot, G., Gutiérrez‐Abril, J., Prieto, M., Ribera‐Cortada, I., Woroniecka, R., Rymkiewicz, G., Bens, S., et al. (2018) · Blood · doi:10.1182/blood-2018-07-862151 · Cited by 107
Conformation of sister chromatids in the replicated human genome
Mitter, M., Gasser, C., Takács, Z., Langer, C. C. H., Tang, W., Jessberger, G., Beales, C. T., Neuner, E., Ameres, S. L., Peters, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2744-4 · Cited by 111
Cancer whole-genome sequencing: present and future
Nakagawa, H., Wardell, C. P., Furuta, M., Taniguchi, H., & Fujimoto, A. (2015) · Oncogene · doi:10.1038/onc.2015.90 · Cited by 111
Chromatin features constrain structural variation across evolutionary timescales
Fudenberg, G., & Pollard, K. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808631116 · Cited by 107
An epigenetic gateway to brain tumor cell identity
Mack, S. C., Hubert, C. G., Miller, T. E., Taylor, M. D., & Rich, J. N. (2015) · Nature Neuroscience · doi:10.1038/nn.4190 · Cited by 106
Self-citation
Metadata
- Authors
- Northcott, P. A., Lee, C., Zichner, T., Stütz, A. M., Erkek, S., Kawauchi, D., Shih, D. J. H., Hovestadt, V., Zapatka, M., Sturm, D., Jones, D. T. W., Kool, M., Remke, M., Cavalli, F. M. G., Zuyderduyn, S., Bader, G. D., VandenBerg, S., Esparza, L. A., Ryzhova, M., Wang, W., Wittmann, A., Stark, S., Sieber, L., Seker-Cin, H., Linke, L., Kratochwil, F., Jäger, N., Buchhalter, I., Imbusch, C. D., Zipprich, G., Raeder, B., Schmidt, S., Diessl, N., Wolf, S., Wiemann, S., Brors, B., Lawerenz, C., Eils, J., Warnatz, H.-J., Risch, T., Yaspo, M.-L., Weber, U. D., Bartholomae, C. C., von Kalle, C., Turányi, E., Hauser, P., Sanden, E., Darabi, A., Siesjö, P., Sterba, J., Zitterbart, K., Sumerauer, D., van Sluis, P., Versteeg, R., Volckmann, R., Koster, J., Schuhmann, M. U., Ebinger, M., Grimes, H. L., Robinson, G. W., Gajjar, A., Mynarek, M., von Hoff, K., Rutkowski, S., Pietsch, T., Scheurlen, W., Felsberg, J., Reifenberger, G., Kulozik, A. E., von Deimling, A., Witt, O., Eils, R., Gilbertson, R. J., Korshunov, A., Taylor, M. D., Lichter, P., Korbel, J. O., Wechsler-Reya, R. J., & Pfister, S. M.
- Affiliations
- German Cancer Research Center (DE)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- European Molecular Biology Laboratory (DE)
- Hospital for Sick Children (CA)
- University of Toronto (CA)
- University of California San Diego (US)
- Burdenko Neurosurgery Institute (RU)
- Max Planck Institute for Molecular Genetics (DE)
- Semmelweis University (HU)
- Lund University (SE)
- Masaryk University (CZ)
- Charles University (CZ)
- Amsterdam UMC Location University of Amsterdam (NL)
- Universitätsklinikum Tübingen (DE)
- Cincinnati Children's Hospital Medical Center (US)
- St. Jude Children's Research Hospital (US)
- University Medical Center Hamburg-Eppendorf (DE)
- University of Bonn (DE)
- Cnopf´sche Kinderklinik (DE)
- Heinrich Heine University Düsseldorf (DE)
- University Hospital Heidelberg (DE)
- Heidelberg University (DE)
- European Bioinformatics Institute (GB)
- Corresponding author
- Lichter, Peter
- Korbel, Jan O.
- Pfister, Stefan M.
- ORCID
- Northcott, Paul A.
- Lee, Catherine
- Zichner, Thomas
- Stütz, Adrian M.
- Erkek, Serap
- Kawauchi, Daisuke
- Shih, David J. H.
- Hovestadt, Volker
- Zapatka, Marc
- Sturm, Dominik
- Jones, David T. W.
- Kool, Marcel
- Remke, Marc
- Cavalli, Florence M. G.
- Bader, Gary D.
- VandenBerg, Scott
- Esparza, Lourdes Adriana
- Ryzhova, Marina
- Wang, Wei
- Linke, Linda
- Jäger, Natalie
- Buchhalter, Ivo
- Imbusch, Charles D.
- Raeder, Benjamin
- Schmidt, Sabine
- Wiemann, Stefan
- Brors, Benedikt
- Warnatz, Hans-Jörg
- Yaspo, Marie-Laure
- Darabi, Anna
- Siesjö, Peter
- Sumerauer, David
- Versteeg, Rogier
- Volckmann, Richard
- Schuhmann, Martin U.
- Ebinger, Martin
- Grimes, H. Leighton
- Robinson, Giles W.
- Gajjar, Amar
- Mynarek, Martin
- Rutkowski, Stefan
- Pietsch, Torsten
- Felsberg, Jörg
- Reifenberger, Guido
- Kulozik, Andreas E.
- Witt, Olaf
- Eils, Roland
- Gilbertson, Richard J.
- Korshunov, Andrey
- Taylor, Michael D.
- Lichter, Peter
- Korbel, Jan O.
- Pfister, Stefan M.
- Venue
- Nature
- Published
- 2014-06-22
- Volume
- 511
- Issue
- 7510
- Pages
- 428-434
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4201514
- OpenAlex
- W2161535481
- Cited by
- 642
- References
- 47
- Citations by year
- 2026: 26 · 2025: 47 · 2024: 51 · 2023: 59 · 2022: 66 · 2021: 75 · 2020: 62 · 2019: 64 · 2018: 51 · 2017: 49 · 2016: 47 · 2015: 36 · 2014: 6
- FWCI
- 23.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Semmelweis University Repository (Semmelweis University) (submittedVersion)
- Funders
- California Institute for Regenerative Medicine (LA1-01747)
- CureSearch for Children's Cancer
- Deutsches Krebsforschungszentrum
- European Commission (260791)
- Bundesministerium für Bildung und Forschung (01KU1201A, 01GS0883)
- Deutsche Krebshilfe (109252)
- Hospital for Sick Children
- Stichting Kinderen Kankervrij
- Nationales Centrum für Tumorerkrankungen Heidelberg
- Partenariat Canadien Contre Le Cancer
- National Institutes of Health (UL1TR001425, GM 103504)
- University of California, San Diego
- Heidelberger Zentrum für Personalisierte Onkologie Deutsches Krebsforschungszentrum In Der Helmholtz-Gemeinschaft
- National Cancer Institute (R01CA129541, CA159859, P30CA030199, R01CA159859, P01CA096832)
- National Institute of General Medical Sciences (P41GM103504)
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- medulloblastoma, enhancer hijacking, GFI1, GFI1B, oncogene activation, super-enhancers, structural variants, Group 3 medulloblastoma, Group 4 medulloblastoma, pediatric brain tumors, oncogenic drivers
- MeSH terms
- Animals, Child, Chromosomes, Human, Pair 9, DNA-Binding Proteins, Enhancer Elements, Genetic, Humans, Medulloblastoma, Oncogenes, Proto-Oncogene Proteins, Repressor Proteins, Transcription Factors, Mice, Genomic Structural Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
